Commonwealth of Pennsylvania Public School Empls Retrmt SYS Decreases Stake in STERIS plc (NYSE:STE)

Commonwealth of Pennsylvania Public School Empls Retrmt SYS reduced its stake in STERIS plc (NYSE:STE) by 2.2% in the 4th quarter, HoldingsChannel.com reports. The firm owned 20,988 shares of the medical equipment provider’s stock after selling 480 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in STERIS were worth $4,314,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Avalon Trust Co purchased a new position in STERIS during the 4th quarter worth approximately $30,000. Human Investing LLC purchased a new position in shares of STERIS during the 4th quarter valued at approximately $31,000. Anfield Capital Management LLC increased its holdings in shares of STERIS by 100.0% during the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock valued at $37,000 after purchasing an additional 91 shares in the last quarter. Central Pacific Bank Trust Division increased its holdings in shares of STERIS by 65.5% during the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock valued at $39,000 after purchasing an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC increased its holdings in shares of STERIS by 182.7% during the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after purchasing an additional 137 shares in the last quarter. 94.69% of the stock is owned by hedge funds and other institutional investors.

STERIS Trading Down 2.3 %

Shares of STE opened at $220.34 on Monday. STERIS plc has a 52-week low of $197.82 and a 52-week high of $248.24. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The firm’s fifty day moving average is $221.02 and its two-hundred day moving average is $221.84. The stock has a market cap of $21.65 billion, a PE ratio of 46.78 and a beta of 0.92.

STERIS (NYSE:STE) last announced its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Research analysts forecast that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were paid a dividend of $0.57 per share. The ex-dividend date was Thursday, February 20th. This represents a $2.28 annualized dividend and a yield of 1.03%. STERIS’s dividend payout ratio (DPR) is presently 48.41%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. Piper Sandler lifted their target price on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. JMP Securities reissued a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a research note on Thursday, February 6th. Finally, Stephens reissued an “overweight” rating and issued a $240.00 price target on shares of STERIS in a research note on Thursday, February 6th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, STERIS has an average rating of “Moderate Buy” and an average price target of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.